| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 2.64e-04 | 22 | 22 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 3.15e-04 | 24 | 22 | 2 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 3.42e-04 | 25 | 22 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 4.00e-04 | 27 | 22 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.99e-03 | 560 | 22 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.11e-03 | 566 | 22 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.45e-03 | 1412 | 22 | 6 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 4.06e-03 | 1459 | 22 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 5.06e-03 | 97 | 22 | 2 | GO:0008081 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 3.89e-05 | 9 | 22 | 2 | GO:0006198 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide catabolic process | 9.81e-05 | 14 | 22 | 2 | GO:0009214 | |
| GeneOntologyBiologicalProcess | pons development | 1.13e-04 | 15 | 22 | 2 | GO:0021548 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity of embryonic epithelium | 1.64e-04 | 18 | 22 | 2 | GO:0042249 | |
| GeneOntologyBiologicalProcess | brain development | 2.16e-04 | 859 | 22 | 6 | GO:0007420 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.47e-04 | 1269 | 22 | 7 | GO:0009887 | |
| GeneOntologyBiologicalProcess | head development | 3.11e-04 | 919 | 22 | 6 | GO:0060322 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 3.21e-04 | 25 | 22 | 2 | GO:0046058 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 4.34e-04 | 343 | 22 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | tube development | 4.54e-04 | 1402 | 22 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 4.73e-04 | 351 | 22 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 5.28e-04 | 32 | 22 | 2 | GO:0048596 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 7.46e-04 | 38 | 22 | 2 | GO:0048048 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 7.85e-04 | 713 | 22 | 5 | GO:0048598 | |
| GeneOntologyBiologicalProcess | lung cell differentiation | 9.11e-04 | 42 | 22 | 2 | GO:0060479 | |
| GeneOntologyBiologicalProcess | lung epithelial cell differentiation | 9.11e-04 | 42 | 22 | 2 | GO:0060487 | |
| GeneOntologyBiologicalProcess | tube formation | 9.95e-04 | 187 | 22 | 3 | GO:0035148 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 1.00e-03 | 44 | 22 | 2 | GO:0001736 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 1.00e-03 | 44 | 22 | 2 | GO:0052652 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 1.05e-03 | 45 | 22 | 2 | GO:0007164 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 1.05e-03 | 45 | 22 | 2 | GO:0031076 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 1.05e-03 | 45 | 22 | 2 | GO:0009187 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.24e-03 | 202 | 22 | 3 | GO:0021915 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.26e-03 | 1197 | 22 | 6 | GO:0007417 | |
| GeneOntologyBiologicalProcess | hindbrain development | 1.35e-03 | 208 | 22 | 3 | GO:0030902 | |
| Domain | PDZ | 2.47e-05 | 141 | 23 | 4 | PF00595 | |
| Domain | PDZ | 2.98e-05 | 148 | 23 | 4 | SM00228 | |
| Domain | - | 3.14e-05 | 150 | 23 | 4 | 2.30.42.10 | |
| Domain | PDZ | 3.23e-05 | 151 | 23 | 4 | PS50106 | |
| Domain | PDZ | 3.31e-05 | 152 | 23 | 4 | IPR001478 | |
| Domain | PDEase | 2.45e-04 | 19 | 23 | 2 | IPR023088 | |
| Domain | PDEase_I | 3.00e-04 | 21 | 23 | 2 | PF00233 | |
| Domain | PDEASE_I | 3.00e-04 | 21 | 23 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.00e-04 | 21 | 23 | 2 | IPR023174 | |
| Domain | - | 3.30e-04 | 22 | 23 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 3.61e-04 | 23 | 23 | 2 | IPR002073 | |
| Domain | HDc | 3.94e-04 | 24 | 23 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 3.94e-04 | 24 | 23 | 2 | IPR003607 | |
| Domain | TF_fork_head_CS_2 | 1.45e-03 | 46 | 23 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.52e-03 | 47 | 23 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 1.65e-03 | 49 | 23 | 2 | PS50039 | |
| Domain | FH | 1.65e-03 | 49 | 23 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.65e-03 | 49 | 23 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.65e-03 | 49 | 23 | 2 | PS00658 | |
| Domain | Forkhead | 1.65e-03 | 49 | 23 | 2 | PF00250 | |
| Domain | Fork_head_dom | 1.65e-03 | 49 | 23 | 2 | IPR001766 | |
| Domain | zf-C3HC4 | 2.49e-03 | 223 | 23 | 3 | PF00097 | |
| Domain | ZF_RING_1 | 5.26e-03 | 291 | 23 | 3 | PS00518 | |
| Domain | ZF_RING_2 | 5.62e-03 | 298 | 23 | 3 | PS50089 | |
| Domain | RING | 5.99e-03 | 305 | 23 | 3 | SM00184 | |
| Domain | Znf_RING | 7.20e-03 | 326 | 23 | 3 | IPR001841 | |
| Domain | Znf_RING_CS | 1.70e-02 | 163 | 23 | 2 | IPR017907 | |
| Domain | Znf_C3HC4_RING-type | 1.88e-02 | 172 | 23 | 2 | IPR018957 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 2.03e-06 | 36 | 24 | 3 | 26053890 | |
| Pubmed | FOXF2 is required for cochlear development in humans and mice. | 1.64e-05 | 9 | 24 | 2 | 30561639 | |
| Pubmed | 2.50e-05 | 11 | 24 | 2 | 28506991 | ||
| Pubmed | The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis. | 3.00e-05 | 12 | 24 | 2 | 32758357 | |
| Pubmed | 9.51e-05 | 21 | 24 | 2 | 16079250 | ||
| Pubmed | 1.36e-04 | 25 | 24 | 2 | 17307970 | ||
| Pubmed | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. | 1.36e-04 | 25 | 24 | 2 | 19786569 | |
| Pubmed | 1.59e-04 | 27 | 24 | 2 | 25631042 | ||
| Pubmed | 1.83e-04 | 29 | 24 | 2 | 36800290 | ||
| Pubmed | 2.24e-04 | 32 | 24 | 2 | 38110169 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 2.53e-04 | 34 | 24 | 2 | 30726710 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.37e-04 | 908 | 24 | 5 | 19274049 | |
| Pubmed | 5.08e-04 | 549 | 24 | 4 | 38280479 | ||
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 5.48e-04 | 50 | 24 | 2 | 27716508 | |
| Interaction | KRTAP12-4 interactions | 3.34e-05 | 53 | 24 | 3 | int:KRTAP12-4 | |
| Interaction | FTHL17 interactions | 4.87e-05 | 9 | 24 | 2 | int:FTHL17 | |
| Interaction | CD164 interactions | 4.87e-05 | 9 | 24 | 2 | int:CD164 | |
| Interaction | KRTAP12-1 interactions | 5.62e-05 | 63 | 24 | 3 | int:KRTAP12-1 | |
| Interaction | KRTAP13-4 interactions | 6.08e-05 | 10 | 24 | 2 | int:KRTAP13-4 | |
| Interaction | YWHAZ interactions | 9.41e-05 | 1319 | 24 | 8 | int:YWHAZ | |
| GeneFamily | PDZ domain containing | 1.05e-05 | 152 | 17 | 4 | 1220 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.08e-04 | 23 | 17 | 2 | 662 | |
| GeneFamily | Phosphodiesterases | 2.27e-04 | 24 | 17 | 2 | 681 | |
| GeneFamily | Forkhead boxes | 7.35e-04 | 43 | 17 | 2 | 508 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 7.84e-06 | 141 | 24 | 4 | M39235 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 1.52e-05 | 800 | 23 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.76e-06 | 200 | 24 | 4 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.76e-06 | 200 | 24 | 4 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-05 | 137 | 24 | 3 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 166 | 24 | 3 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 166 | 24 | 3 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 169 | 24 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.94e-05 | 169 | 24 | 3 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.10e-04 | 175 | 24 | 3 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 178 | 24 | 3 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 179 | 24 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 181 | 24 | 3 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.30e-04 | 185 | 24 | 3 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 188 | 24 | 3 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 191 | 24 | 3 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 192 | 24 | 3 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 192 | 24 | 3 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-04 | 193 | 24 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 195 | 24 | 3 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 195 | 24 | 3 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 195 | 24 | 3 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 196 | 24 | 3 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-04 | 197 | 24 | 3 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| Drug | E 4021 | 2.93e-06 | 3 | 23 | 2 | ctd:C091517 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 5.05e-05 | 107 | 20 | 3 | EFO_0004614, EFO_0004615 | |
| Disease | Cholangiocarcinoma | 1.40e-04 | 26 | 20 | 2 | C0206698 | |
| Disease | metabolic syndrome | 3.21e-04 | 200 | 20 | 3 | EFO_0000195 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.25e-04 | 45 | 20 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.24e-04 | 50 | 20 | 2 | EFO_0022247 | |
| Disease | triglycerides in medium VLDL measurement | 6.34e-04 | 55 | 20 | 2 | EFO_0022155 | |
| Disease | phospholipids in medium HDL measurement | 6.34e-04 | 55 | 20 | 2 | EFO_0022295 | |
| Disease | triglycerides in very large VLDL measurement | 6.58e-04 | 56 | 20 | 2 | EFO_0022325 | |
| Disease | triglycerides in large VLDL measurement | 6.58e-04 | 56 | 20 | 2 | EFO_0022178 | |
| Disease | free cholesterol in medium HDL measurement | 7.05e-04 | 58 | 20 | 2 | EFO_0022267 | |
| Disease | total lipids in medium HDL measurement | 7.05e-04 | 58 | 20 | 2 | EFO_0022310 | |
| Disease | triglycerides in VLDL measurement | 7.30e-04 | 59 | 20 | 2 | EFO_0022326 | |
| Disease | cholesterol in medium HDL measurement | 7.30e-04 | 59 | 20 | 2 | EFO_0021903 | |
| Disease | cholesterol to total lipids in IDL percentage | 7.55e-04 | 60 | 20 | 2 | EFO_0022233 | |
| Disease | triglycerides to total lipids in large HDL percentage | 7.55e-04 | 60 | 20 | 2 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 7.55e-04 | 60 | 20 | 2 | EFO_0022314 | |
| Disease | free cholesterol in very large VLDL measurement | 7.80e-04 | 61 | 20 | 2 | EFO_0022274 | |
| Disease | triglycerides in small VLDL measurement | 7.80e-04 | 61 | 20 | 2 | EFO_0022145 | |
| Disease | phospholipids in HDL measurement | 7.80e-04 | 61 | 20 | 2 | EFO_0022293 | |
| Disease | triglycerides in medium LDL measurement | 8.05e-04 | 62 | 20 | 2 | EFO_0022322 | |
| Disease | phospholipids in large VLDL measurement | 8.05e-04 | 62 | 20 | 2 | EFO_0022169 | |
| Disease | phospholipids in very large VLDL measurement | 8.05e-04 | 62 | 20 | 2 | EFO_0022299 | |
| Disease | total lipids in very large VLDL measurement | 8.05e-04 | 62 | 20 | 2 | EFO_0022313 | |
| Disease | total lipids in HDL measurement | 8.32e-04 | 63 | 20 | 2 | EFO_0022307 | |
| Disease | cholesterol in very large VLDL measurement | 8.85e-04 | 65 | 20 | 2 | EFO_0022230 | |
| Disease | triglycerides in small LDL measurement | 8.85e-04 | 65 | 20 | 2 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 8.85e-04 | 65 | 20 | 2 | EFO_0021902 | |
| Disease | total lipids in large VLDL | 9.40e-04 | 67 | 20 | 2 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 9.68e-04 | 68 | 20 | 2 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 9.68e-04 | 68 | 20 | 2 | EFO_0022265 | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.08e-03 | 72 | 20 | 2 | EFO_0022336 | |
| Disease | testosterone measurement | 1.35e-03 | 1275 | 20 | 5 | EFO_0004908 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.20e-03 | 103 | 20 | 2 | EFO_0008595, EFO_0020944 | |
| Disease | lipoprotein measurement | 2.29e-03 | 105 | 20 | 2 | EFO_0004732 | |
| Disease | verbal-numerical reasoning measurement | 3.53e-03 | 131 | 20 | 2 | EFO_0008394 | |
| Disease | very low density lipoprotein particle size measurement | 3.63e-03 | 133 | 20 | 2 | EFO_0008594 | |
| Disease | electrocardiography | 5.23e-03 | 530 | 20 | 3 | EFO_0004327 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.79e-03 | 169 | 20 | 2 | DOID:3908 (is_marker_for) | |
| Disease | Diuretic use measurement | 5.79e-03 | 169 | 20 | 2 | EFO_0009928 | |
| Disease | neuroticism measurement, cognitive function measurement | 6.28e-03 | 566 | 20 | 3 | EFO_0007660, EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYHQYHNQPIHSVSE | 301 | Q2KHT4 | |
| SCVQHQPHVYPATYH | 531 | Q6NXP0 | |
| QALYATVHQSYPHHA | 851 | Q8WWM7 | |
| SPYKHAHIPAHAQHY | 866 | Q9UPQ7 | |
| YNSSIHHPGYLSDSH | 161 | P26045 | |
| NSHDHGFPNHQYNSY | 201 | O14497 | |
| HSSSSQHHTPPPYYS | 436 | Q8N448 | |
| YHSQNPYHNAVHAAD | 166 | Q9NP56 | |
| EANYHSSNPYHNSTH | 546 | O60658 | |
| PYDEISAVHQHSYHP | 61 | Q12986 | |
| SPQYIHHSYGQEHQS | 156 | P49639 | |
| GYPPEDHSYQHLSSH | 76 | A8K830 | |
| RPHNHPLATYHYTGS | 816 | Q6PJG2 | |
| YPSFHYTHNPSQAEK | 891 | O95487 | |
| YPQAQHSHYPHYAAS | 31 | Q9UJV8 | |
| HSHYPHYAASATPNQ | 36 | Q9UJV8 | |
| PSASGSYYHHHHQSV | 421 | Q12947 | |
| PEHHYAFNHPFSINN | 366 | Q9Y261 | |
| TYSNSHGPYDSNQPH | 481 | P0DPF3 | |
| YSNSHGPYDSNQPHR | 211 | A0A087WUL8 | |
| SYQNADSYHHHTSPQ | 1046 | Q9Y2K2 | |
| HSADQPYHATDQSYH | 831 | Q9ULL8 | |
| YYIDHNTNTTHWSHP | 216 | Q9H4B6 | |
| LSSHYLCNTPPHYHG | 671 | O15455 | |
| AYTHASPIHNTHKPY | 151 | Q9Y6R6 | |
| HSALYLSSHYHQQPG | 366 | O94900 |